Jiangsu Skyray Instrument Co., Ltd.

SZSE:300165 Stock Report

Market Cap: CN¥2.0b

Jiangsu Skyray Instrument Past Earnings Performance

Past criteria checks 0/6

Jiangsu Skyray Instrument's earnings have been declining at an average annual rate of -57.1%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 4.7% per year.

Key information

-57.1%

Earnings growth rate

-56.5%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate4.7%
Return on equity-9.1%
Net Margin-13.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Shares Fly 40% But Investors Aren't Buying For Growth

Sep 30
Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Shares Fly 40% But Investors Aren't Buying For Growth

Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Held Back By Insufficient Growth Even After Shares Climb 30%

Aug 15
Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Held Back By Insufficient Growth Even After Shares Climb 30%

Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Not Doing Enough For Some Investors As Its Shares Slump 30%

Jun 04
Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Not Doing Enough For Some Investors As Its Shares Slump 30%

Why Investors Shouldn't Be Surprised By Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) 28% Share Price Plunge

Apr 17
Why Investors Shouldn't Be Surprised By Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) 28% Share Price Plunge

Returns On Capital At Jiangsu Skyray Instrument (SZSE:300165) Paint A Concerning Picture

Apr 15
Returns On Capital At Jiangsu Skyray Instrument (SZSE:300165) Paint A Concerning Picture

Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) Business And Shares Still Trailing The Industry

Feb 27
Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) Business And Shares Still Trailing The Industry

Revenue & Expenses Breakdown

How Jiangsu Skyray Instrument makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300165 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24964-13333485
30 Jun 24961-15334488
31 Mar 24961-13231689
31 Dec 231,017-11431884
30 Sep 231,342-3729776
30 Jun 231,418-6531184
31 Mar 231,351-10532979
01 Jan 231,404-8833880
30 Sep 221,316-9534079
30 Jun 221,559-6934971
31 Mar 221,578-4434773
01 Jan 221,542-5434875
30 Sep 211,325-132074
30 Jun 211,0355530970
31 Mar 211,0002032768
31 Dec 209362130959
30 Sep 208582430861
30 Jun 20827-2731367
31 Mar 208691928764
31 Dec 199082129872
30 Sep 19961835579
30 Jun 199864231169
31 Mar 199953231671
31 Dec 181,0243630769
30 Sep 181,0028426163
30 Jun 189488423795
31 Mar 1888811022379
31 Dec 1779210422064
30 Sep 175937020742
30 Jun 17518612330
31 Mar 17461592110
31 Dec 16430562020
30 Sep 16382581840
30 Jun 16357541800
31 Mar 16337471760
31 Dec 15321451730
30 Sep 15289471660
30 Jun 15285561620
31 Mar 15274491650
31 Dec 14277501650
30 Sep 14295561750
30 Jun 14309511810
31 Mar 14317561850
31 Dec 13325561920

Quality Earnings: 300165 is currently unprofitable.

Growing Profit Margin: 300165 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300165 is unprofitable, and losses have increased over the past 5 years at a rate of 57.1% per year.

Accelerating Growth: Unable to compare 300165's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300165 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).


Return on Equity

High ROE: 300165 has a negative Return on Equity (-9.08%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies